AVADEL PHARMACEUTICALS PLC Annual Net Cash Provided by (Used in) Financing Activities in USD from 2010 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Avadel Pharmaceuticals Plc quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2010 to 2023.
  • Avadel Pharmaceuticals Plc Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was $13.2M, a 61.7% decline year-over-year.
  • Avadel Pharmaceuticals Plc annual Net Cash Provided by (Used in) Financing Activities for 2023 was $135M, a 831% increase from 2022.
  • Avadel Pharmaceuticals Plc annual Net Cash Provided by (Used in) Financing Activities for 2022 was $14.5M, a 5430% increase from 2021.
  • Avadel Pharmaceuticals Plc annual Net Cash Provided by (Used in) Financing Activities for 2021 was $263K, a 99.9% decline from 2020.
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $135M +$121M +831% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-29
2022 $14.5M +$14.3M +5430% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-29
2021 $263K -$179M -99.9% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-29
2020 $180M +$180M Jan 1, 2020 Dec 31, 2020 10-K 2022-03-16
2019 -$27K -$113M -100% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-16
2018 $113M +$136M Jan 1, 2018 Dec 31, 2018 10-K 2021-03-09
2017 -$23.3M -$15.4M -193% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-16
2016 -$7.95M +$15.8M +66.5% Jan 1, 2016 Dec 31, 2016 10-K 2019-03-15
2015 -$23.8M -$120M -125% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-16
2014 $96M +$77.7M +425% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-28
2013 $18.3M +$11.3M +163% Jan 1, 2013 Dec 31, 2013 10-K 2016-03-15
2012 $6.96M +$810K +13.2% Jan 1, 2012 Dec 31, 2012 20-F/A 2015-10-01
2011 $6.15M +$6.92M Jan 1, 2011 Dec 31, 2011 20-F/A 2014-04-30
2010 -$774K Jan 1, 2010 Dec 31, 2010 20-F 2013-04-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.